Abbott Laboratories (ABT) EBITDA Margin (2009 - 2026)
Abbott Laboratories (ABT) reported EBITDA Margin of 12.05% for Q1 2026, down 430.0% on a YoY basis from 3.65% in Q1 2025, and down 38.67% sequentially from 19.64% in Q4 2025.
Abbott Laboratories (ABT) EBITDA Margin (2009 - 2026) Analysis & Trends
Abbott Laboratories (ABT) has 18 years of EBITDA Margin data on file, last reported at 12.05% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 430.0% year-over-year to 12.05%; the trailing twelve-month figure through Mar 2026 stood at 17.07% (up 23.0% YoY), and the FY2025 full-year result was 18.17%, up 190.0% from the prior year.
- EBITDA Margin slipped to 12.05% in Q1 2026, from 19.64% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 24.48% in Q1 2022 to a low of 12.05% in Q1 2026.
- A 5-year average of 17.03% and a median of 17.0% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin surged 749 bps in 2022 and plunged 900 bps in 2023, its largest moves.
- Tracing ABT's EBITDA Margin over 5 years: stood at 12.92% in 2022, then soared by 35 bps to 17.38% in 2023, then advanced by 0 bps to 17.41% in 2024, then rose by 13 bps to 19.64% in 2025, then tumbled by 39 bps to 12.05% in 2026.
- Business Quant data shows ABT's EBITDA Margin at 12.05% in Q1 2026, 19.64% in Q4 2025, and 18.09% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 19.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.05% |
| Dec 31, 2025 | 19.64% |
| Sep 30, 2025 | 18.09% |
| Jun 30, 2025 | 18.42% |
| Mar 31, 2025 | 16.34% |
| Dec 31, 2024 | 17.41% |
| Sep 30, 2024 | 17.48% |
| Jun 30, 2024 | 16.08% |
| Mar 31, 2024 | 13.91% |
| Dec 31, 2023 | 17.38% |
| Sep 30, 2023 | 16.24% |
| Jun 30, 2023 | 15.45% |
| Mar 31, 2023 | 15.48% |
| Dec 31, 2022 | 12.92% |
| Sep 30, 2022 | 17.00% |
| Jun 30, 2022 | 21.11% |
| Mar 31, 2022 | 24.48% |
| Dec 31, 2021 | 20.74% |
| Sep 30, 2021 | 23.30% |
| Jun 30, 2021 | 13.62% |